Fazirsiran

DB17891InvestigationalGene Therapies

Fazirsiran: Overview.

Mechanism
Curator reviewed
Also known as
Ads-001 free acid · ARO-AAT · RNA, ((1'-DE(6-AMINO-9H-PURIN-9-YL))DA-(5'->5')-SP-AM-GM-CM-GM-UM-UM- UM-AM-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)G-(2'-DEOXY-2'-FLUORO)C-AM- UM-GM-UM-UM-UM-AM-AM-CM-AM-(3'->3')-SP-(1'-DE(6-AMINO-9H-PURIN-9- YL))DA), 3'-(O-(CIS-4-((3S,8S)-17-((2-(ACE · TAK-999
Code names
ADS-001

Resolves to

Compound
UNIIV20IVC0OGQCAS2175009-08-0
Targets
P01009SERPINA1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fazirsiran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In